Further, decreased COX7B levels significantly predicted patient mortality in the following solid tumors: adrenocortical carcinoma, colorectal adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma, non‐small‐cell lung cancer, and ovarian cancer (Figure 3D‐H),37, 38 which all are plausible candidates for platinum treatment in the clinic. Here, COX7B is linked to colorectal adenocarcinoma.